I spoke to a rheumatologist the other day who has been in touch with Genentech, the drug company that makes Actemra. She said they are pushing for Actemra to be approved, for PMR by the FDA and are hoping to get the approval fast tracked, within a year or so.
I know there's many a slip, but sounds good. Apparently the issue is no longer whether Actemra works for PMR. The total Pred load is 1/2 on Actemra than on Pred. alone. Hence fewer side effects, etc. The question they are studying now is how long it needs to be administered.
I know no more. I should have asked if any studies had been done using Actemra as a solo agent. I don't remember seeing reference to any. On ClinicalTrials.gov (US website) iirc, the GCA study only took people who had been recently diagnosed and only on Pred for a pretty short time.
I know we've had a recent discussion here about the class action lawsuit against Genentech/LaRoche for not having disclosed or studied the longer term side effects of Actemra, some serious. I asked about her about this and she was unaware of it. She did say that all the biologics and all the diseases that are treated with them have some of those same serious side effects/outcomes.
Just an fyi.